Blood News and Research

RSS

Severity of sleep apnoea can independently predict aggressiveness of skin melanoma

The severity of sleep apnoea can independently predict the aggressiveness of malignant skin melanoma, according to a new study.

10 Sep 2013

Scientists identify gene variant that predisposes people to special type of heart attack

Scientists at The University of Manchester and medical institutes in Italy have identified a gene variant that predisposes people to a special type of heart attack.

From The University of Manchester 10 Sep 2013

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.

10 Sep 2013

Children's National receives grant to identify early signs of prenatal brain injury caused by CHD

Children's National Medical Center has received a five-year grant from the National Institutes of Health to identify reliable early signs of prenatal brain injury caused by congenital heart disease. Catherine Limperopoulos, PhD, Director of the Advanced Pediatric Brain Imaging Research Laboratory at Children's National will lead the study.

10 Sep 2013

Ferritin protects kidneys against damage by controlling iron

A protein, ferritin, protects kidneys against a damaging after-effect of injury, heart failure or hardened arteries by controlling levels of iron, according to a study published today by researchers at the University of Alabama at Birmingham in the Journal of Clinical Investigation.

10 Sep 2013

Breath tests could be non-invasive method of diagnosing lung cancer

Collecting samples of exhaled breath from people at a high risk of lung cancer could be a cheap and non-invasive method of diagnosing the disease, according to new research.

10 Sep 2013

UCSF scientists identify new way to manipulate immune system from autoimmune diseases

Scientists from UC San Francisco have identified a new way to manipulate the immune system that may keep it from attacking the body-s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.

10 Sep 2013

European launch of new version of REVIVE™ SE Thrombectomy Device for treatment of acute ischemic stroke announced by Codman Neuro

Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, announced the European launch of the REVIVE™ SE Thrombectomy Device, a next generation clot removal device offering enhanced navigation through the cerebral vasculature and rapid restoration of blood flow to the brain after an ischemic stroke.

9 Sep 2013

Neural clue to poor daytime concentration in insomnia

Researchers have found abnormal neural function in patients with primary insomnia, which may help explain why these patients find it hard to concentrate on daytime tasks despite the absence of objectively measured cognitive deficits.

9 Sep 2013

Doubt cast on worth of BP load

Blood pressure load may not be a useful clinical measure, say researchers.

9 Sep 2013

Hepatitis C services in the UK: an interview with Louise Campbell, senior liver nurse at Imperial College Healthcare NHS Trust

Within the UK there are several centres whose nurse specialists work to a best practice model, delivering care and achieving outcomes which are extremely high in areas of patient retention, adherence to medication and completion of the treatment regimen. With this they achieve cure rates which are some of the highest in the World.

9 Sep 2013

Sleep-deprived people may buy more high-calorie foods the following day

People who were deprived of one night’s sleep purchased more calories and grams of food in a mock supermarket on the following day in a new study published in the journal Obesity, the official journal of The Obesity Society.

7 Sep 2013

Tenaxis Medical earns EU approval to expand CE Mark indications for ArterX Surgical Sealant

Tenaxis Medical, Inc., (www.tenaxismedical.com), a medical device company focused on the development of functionally designed surgical sealants has received approval from its EU Notified Body, BSI, to expand its CE Mark indications for ArterX Surgical Sealant.

7 Sep 2013

Sam's Club Pharmacy to host free health screenings for diabetes

To promote early detection and an overall healthy lifestyle that can help prevent the onset of diabetes, Sam's Club Pharmacy will host free health screenings Saturday, Sept. 14, from 11 a.m. to 3 p.m.

7 Sep 2013

S&P Capital IQ commences Standard & Poor's Factual Stock Report coverage on Epigenomics AG

S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on Epigenomics AG.

7 Sep 2013

Our Lady of the Lake Trauma Center certified as Level II Trauma Center

The Our Lady of the Lake Trauma Center has earned official designation from the American College of Surgeons and the Louisiana Department of Health and Hospitals as a Level II Trauma Center. This verification makes the Lake's trauma center the only such center in the greater Baton Rouge region.

7 Sep 2013

Experts and patient advocates to discuss growing concerns around blood glucose test strip accuracy

The Diabetes Hands Foundation announced today that it will send diabetes advocate Bennet Dunlap to participate on a panel September 9, 2013 aiming to address the growing concerns around blood glucose test strip accuracy.

7 Sep 2013

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, ablumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.

7 Sep 2013

UW researchers receive $390,000 from 5 organizations dedicated to fostering technology

A product development team at the University of Washington (UW) will receive $390,000 from five organizations dedicated to fostering technology commercialization in Washington.

7 Sep 2013

NIH awards nearly $14M grants to research on how genetic factors influence susceptibility to disease

Five research teams have received new four-year awards to study the genomics of disease susceptibility in ethnically diverse populations. The projects aim to unravel the subtle variations in genetic makeup among groups - including African-Americans, Asian-Americans, Hispanics and more - that may account for differences in risks for conditions such as high blood pressure and high blood lipids, in addition to common diseases such as cancer and heart disease.

7 Sep 2013

Blood News and Research

Severity of sleep apnoea can independently predict aggressiveness of skin melanoma

Scientists identify gene variant that predisposes people to special type of heart attack

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Children's National receives grant to identify early signs of prenatal brain injury caused by CHD

Ferritin protects kidneys against damage by controlling iron

Breath tests could be non-invasive method of diagnosing lung cancer

UCSF scientists identify new way to manipulate immune system from autoimmune diseases

European launch of new version of REVIVE™ SE Thrombectomy Device for treatment of acute ischemic stroke announced by Codman Neuro

Neural clue to poor daytime concentration in insomnia

Doubt cast on worth of BP load

Hepatitis C services in the UK: an interview with Louise Campbell, senior liver nurse at Imperial College Healthcare NHS Trust

Sleep-deprived people may buy more high-calorie foods the following day

Tenaxis Medical earns EU approval to expand CE Mark indications for ArterX Surgical Sealant

Sam's Club Pharmacy to host free health screenings for diabetes

S&P Capital IQ commences Standard & Poor's Factual Stock Report coverage on Epigenomics AG

Our Lady of the Lake Trauma Center certified as Level II Trauma Center

Experts and patient advocates to discuss growing concerns around blood glucose test strip accuracy

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

UW researchers receive $390,000 from 5 organizations dedicated to fostering technology

NIH awards nearly $14M grants to research on how genetic factors influence susceptibility to disease

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News